ADC Therapeutics SA Total Assets 2019-2021 | ADCT

ADC Therapeutics SA total assets from 2019 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
ADC Therapeutics SA Annual Total Assets
(Millions of US $)
2020 $514
2019 $138
2018 $151
ADC Therapeutics SA Quarterly Total Assets
(Millions of US $)
2021-09-30 $638
2021-06-30 $464
2021-03-31 $462
2020-12-31 $514
2020-09-30 $522
2020-06-30 $374
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2018-12-31 $151
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.186B $0.002B
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69